Calit2 Posts Streaming Video of California Stem-Cell Conference

San Diego, CA, October 11, 2005 -- After cooperating on a live webcast from the first stem-cell conference organized by the California Institute for Regenerative Medicine, Calit2 now offers more than two dozen presentions for on-demand viewing.

The conference ran October 1-2. All videos are posted with the exception of the Summary Session, which will be posted shortly.

These files are large, and you'll need at least a broadband (Cable/DSL) connection to view them. The videos stream at 225Kbps.



Speech Title



Zach Hall, Ph.D., President, CIRM

10:02 Watch now

Joan Samuelson, J.D., Member, ICOC
6:05 Watch now

Robert Klein, Chairman, ICOC
16:52 Watch now

Session I

Rob Negrin, M.D., Stanford
Hematopoietic Stem Cell Transplantation: Where We Have Been and Where We Are Going
29:21 Watch now

Jeff Bluestone, Ph.D., University of California, San Francisco
A Cure for Type I Diabetes
32:00 Watch now

Olle Lindvall, M.D., Ph.D., University of Lund, Sweden
Stem Cell Therapy for Human Brain Disease: How Can We Make It Work?
25:23 Watch now

Session II

Edward Penhoet, Ph.D., Vice Chair, ICOC
Stem Cells and Therapies: Lessons from the FDA and Industry
2:39 Watch now

Jane Lebkowski, Ph.D., Geron Corporation
Preclinical Studies to Support Clinical Testing of Stem Cell-Based Therapies
18:06 Watch now

Alan Smith, Ph.D., Cognate Therapeutics, Inc.
GMP Banking, Manufacturing and Quality Control of Stem Cells for Clinical Use
25:38 Watch now

Donald Fink, Ph.D., FDA
Developing Stem Cell-Based Therapies: Engaging the FDA
30:56 Watch now

Session III

Fred Gage, Ph.D., The Salk Institute
Stem Cells as Tools for Disease Research and Therapy
3:33 Watch now

Rudolph Jaenisch, Ph.D., The Whitehead Institute, MIT
SCNT for Understanding Disease
26:34 Watch now

Inder Verma, Ph.D., The Salk Institute
Molecular Manipulation of Embryonic Stem Cells
24:14 Watch now

Peter Schultz, Ph.D.,The Scripps Research Institute
Small Molecules and High-Throughput Screening in Embryonic Stem Cells
21:24 Watch now

Session IV

Peter Andrews, Ph.D., University of Sheffield, UK
Self-Renewal of Stem Cells
4:22 Watch now

Haifan Lin, Ph.D., Duke University School of Medicine
Understanding Stem Cell Self-Renewal: Progress and Prospect
18:31 Watch now

Andras Nagy, Ph.D., Mount Sinai Hospital, Toronto, Canada
Development of Tools for Studying hESC Self-Renewal
23:18 Watch now

Martin Pera, Ph.D., The Monash Institute of Medical Research, Australia
Development of Conditions for Defined Culture and Scale-Up
18:15 Watch now

Session V

Nissim Benvenisty, M.D., Ph.D., Hebrew University of Jerusalem, Israel
How Can We Control Differentiation of ES Cells?
20:31 Watch now

Irving Weissman, M.D., Stanford University
Current Status of in vivo Systems to Monitor Stem Cell Differentiation and Function
39:36 Watch Now

Michael Clarke, M.D., University of Michigan
Bad Stem Cell Choices in Cancer Development
35:11 Watch now

Session VI

Ian Duncan, Ph.D., University of Wisconsin
Bridging the Gap Between Bench and Bedside
Watch now

David Scadden, M.D., Harvard Medical School
The Stem Cell Niche: A Drugable Target?
31:39 Watch now

Jon Odorico, M.D., University of Wisconsin
Hurdles to Overcome in Applying hES Cells for Treatment of Diabetes
31:06 Watch now

Hans Keirstead, Ph.D., University of California, Irvine
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors: A Defined Cell Population for a Defined Need
19:45 Watch now


Zach Hall, Ph.D., President, CIRM
Closing Remarks
19:32 Watch now

Related Links
2004 Salk Stem Cell Symposium